Glaxosmithkline Consumer Healthcare: Update On Scheme Of Amalgamation And Arrangement Between Glaxosmithkline Consumer Healthcare Limited And Hindustan Unilever Limited And Their Respective Shareholders And Creditors | Value Research

Glaxosmithkline Consumer Healthcare: Update On Scheme Of Amalgamation And Arrangement Between Glaxosmithkline Consumer Healthcare Limited And Hindustan Unilever Limited And Their Respective Shareholders And Creditors

Pursuant to Regulation 30(7) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that Honble National Company Law Tribunal (NCLT) Chandigarh Bench vide its order dated February 26 2020 has sanctioned the scheme of amalgamation and arrangement between GlaxoSmithKline Consumer Healthcare Limited (Transferor Company) and Hindustan Unilever Limited (Transferee Company) and their respective shareholders and creditors under Section 230 to 232 of the Companies Act 2013 (Scheme). A copy of the order of Honble NCLT is enclosed.
The effective date of the merger will be communicated to the stock exchanges upon being finalized in accordance with the procedure stated under the approved Scheme of Amalgamation.

Kindly take the same on record.

Click here to view PDF


Other Categories